Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Biocon Ltd. Regulatory Filings 2022

Jun 15, 2022

61176_rns_2022-06-15_7a73f1bd-e38f-4ec5-a9df-6ba4df32e546.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [103 x 40] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423

CIN : L24234KA1978PLC003417 www.biocon.com

June 15, 2022

To,The SecretaryBSE LimitedDepartment of Corporate ServicesPhiroze Jeejeebhoy Towers,Dalal Street,Mumbai – 400 001 To,The SecretaryNational Stock Exchange of India LimitedCorporate Communication DepartmentExchange Plaza, Bandra Kurla ComplexMumbai – 400 050
Scrip Code - 532523 Scrip Symbol - BIOCON

Dear Sir/Madam,

Sub: Meetings conducted with Institutional Investors/Research Analysts.

Ref: Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.

Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meetings were conducted with Institutional Investor/ Research Analysts:

Date Name Type of meeting Location
June 15, 2022 EastspringInvestments(Singapore)Limited In-Person Bangalore
June 15, 2022 Lazard Asset Management LLC In-Person Bangalore

We request you to kindly take above intimation on record.

Thanking You,

Yours faithfully,

For Biocon Limited

==> picture [72 x 32] intentionally omitted <==

==> picture [73 x 76] intentionally omitted <==

_______________ Mayank Verma Company Secretary and Compliance Officer